6 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Control Algorithm ... #Diabetes #DM2 ... #Control #Medication ... #Algorithm #Endocrinology
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Antidiabetic #Medications ... #SideEffects #Table ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology
Summary and links to five landmark trials of intensive control vs standard therapy in DM2:

 UKPDS
trials of intensive control ... standard therapy in DM2 ... pubmed/18539917 #EBM ... VisualAbstract #Endocrinology ... #PrimaryCare #Diabetes
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #medications #table ... comparison #management #endocrinology ... #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... #Mellitus #DM2 ... #Inpatient #Medications ... pharmacology #comparison #table ... #endocrinology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... Insulin dependent DM ... Intraabdominal - Orthopedic ... the type of and indication ... Diabetes regimen